← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
AntibodyJazz Pharmaceuticalsderuxtecan, telisotuzumab v…Phase 2

Zanidatamab (ZW25, ZW25 (Zanidatamab))

HER2+/HR+ Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+5
효능 ORR 33%임상시험 33상태 ACTIVE
CGTBiologicBeijing BiotechPhase 2

AP1903 (AP1903)

Leukemia; Myeloma · Sarcoma

#Sarcoma#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 2%임상시험 32상태 RECRUITING
CGTBiologicstaleHe HuangPhase 1

CAR-T cells chimeric antigen receptor T cells (CAR-T cells chimeric antigen receptor T cells)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
효능 0%임상시험 32상태 RECRUITING
CGTBiologicstaleShanghai Unicar-Therapy Bio-med…vedotin (BV), a CD30-direct…Phase 1

CD30+ CAR T-cells (CD30+ CAR T-cells)

Relapsed or Refractory Lymphoma · CD30

#CD30#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 32상태 RECRUITING
CGTBiologicstaleAbbVievedotin (RC48) with the est…Phase 2

Granulocyte Colony-Stimulating Factor (Granulocyte Colony-Stimulating Factor)

AML, Childhood; Aml · AML, Childhood

#AMLChildhood#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 20.4%임상시험 32상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab plus nivolumab)

Melanoma; Non Small Cell Lung Cancer · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+3
효능 ORR 77.8%임상시험 32상태 RECRUITING
ADCBiologicstaleJanssen Research & Development,…Phase 2

Nirogacestat (Nirogacestat)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 57%임상시험 32상태 RECRUITING
ADCBiologicstaleAkesoaxisPhase 3

Platinum chemotherapy (Platinum chemotherapy)

Advanced Non Small Cell Lung Cancer (NSCLC) · Advanced Non Small Cell Lung Cancer (NSC

#AdvancedNonSmallCellLungCancerNS#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 65.1%임상시험 32상태 RECRUITING
ADCBiologicAstraZenecaderuxtecan and rilvegostomi…Phase 3

Rilvegostomig (Rilvegostomig)

Hepatocellular Carcinoma · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
임상시험 32상태 RECRUITING
CGTBiologicRui Therapeutics Co., LtdPhase 1

anti-CD19 CAR-NK cells (anti-CD19 CAR-NK cells)

Refractory/Recurrent Central Nervous System Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 0%임상시험 32상태 ACTIVE
AntibodystaleAnaveon AGVedotin ± Pe…Phase 2

KEYTRUDA® (ANV600 + pembrolizumab, ANV600 + pembrolizumab (KEYTRUDA®))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#항체#면역항체+4
효능 ORR 71.4%임상시험 31상태 RECRUITING
AntibodystaleETOP IBCSG Partners Foundationderuxtecan (Arm 4), followe…Phase 3

durvalumab (Imfinzi, Adjuvant durvalumab)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+4
효능 ORR 45%임상시험 31상태 RECRUITING
AntibodyBiologicstaleKyverna TherapeuticssPhase 2

Anti-CD20 mAB (Anti-CD20 mAB)

Multiple Sclerosis, Primary Progressive; Multiple Sclerosis, Secondary Progressive · CD20

#CD20#Antibody#Phase2#항체#면역항체+5
효능 ORR 89%임상시험 31상태 RECRUITING
ADCBiologicstaleBeOne MedicinesPhase 1

Anticancer Agents (Anticancer Agents)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 0%임상시험 31상태 RECRUITING
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab - 21 Day Cycle)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 46.4%임상시험 31상태 RECRUITING
CGTBiologicstaleVinmec Research Institute of St…Phase 1

Autologous CD19-Targeted CAR-T Cells (Autologous CD19-Targeted CAR-T Cells)

Refractory Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 92%임상시험 31상태 RECRUITING
CGTBiologicstaleInstitute of Hematology & Blood…Phase 2

Autologous hematopoietic stem cell infusion (Autologous hematopoietic stem cell infusion)

Prolonged Cytopenia Following CAR-T Therapy · Prolonged Cytopenia Following CAR-T Ther

#ProlongedCytopeniaFollowingCAR-T#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 73.33%임상시험 31상태 RECRUITING
CGTBiologicstaleLiaoning Medical Diagnosis and …designPhase 2

Autologous immune Cells (Autologous immune Cells)

Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic) · Lung Cancer (Locally Advanced or Metasta

#LungCancerLocallyAdvancedorMetas#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 31상태 RECRUITING
AntibodystaleRocheVedotin in Relapsed/Refract…Phase 2

Glofitamab/Obinutuzumab (Glofitamab/Obinutuzumab)

Richter Syndrome · FRα

#FR#Antibody#Phase2#항체#면역항체+5
효능 ORR 35.3%임상시험 31상태 RECRUITING
AntibodystaleMerck Sharp & Dohme LLCADCsPhase 3

H1 receptor antagonist (H1 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#항체#면역항체+5
효능 ORR 6%임상시험 31상태 RECRUITING

30 / 177 페이지

← 이전다음 →